Expression of Skp2, a p27Kip1 ubliquitin ligase, in malignant lymphoma:: correlation with p27Kip1 and proliferation index
Expression of Skp2, a p27Kip1 ubliquitin ligase, in malignant lymphoma:: correlation with p27Kip1 and proliferation index
复制标题
DOI:
10.1182/blood.v100.8.2950
复制
发表时间:
2002-10-15
期刊:
影响因子:
20.3
通讯作者:
Elenitoba-Johnson, KSJ
中科院分区:
文献类型:
--
作者:
Lim, MS;Adamson, A;Elenitoba-Johnson, KSJ
Reduced levels of p27(Kip1) are frequent in human cancers and have been associated with poor prognosis. Skp2, a component of the Skp1-Cul1-F-box protein (SCF) ubiquitin ligase complex, has been implicated in p27(Kip1) degradation. Increased Skp2 levels are seen in some solid tumors and are associated with reduced p27(Kip1). We examined the expression of these proteins using single and double immunolabeling in a large series of lymphomas to determine if alterations in their relative levels are associated with changes in cell proliferation and lymphoma subgroups; We studied the expression of Skp2 in low-grade and aggressive B-cell lymphomas (n=86) and compared them with p27(Kip1) and the proliferation index (PI). Fifteen hematopoietic cell lines and peripheral blood lymphocytes were studied by Western blot analysis. In reactive tonsils, Skp2 expression was limited to proliferating germinal center and interfollicular cells. Skp2 expression in small lymphocytic lymphomas (SLLs) and follicular lymphomas (FCLs) was low (mean percentage of positive tumor cells, less than 20%) and was inversely correlated (r=-0.67; P